Quantification of follow-up time in oncology clinical trials with a time-to-event endpoint: Asking the right questions

Kaspar Rufibach, Lynda Grinsted, Jiang Li +3

For the analysis of a time-to-event endpoint in a single-arm or randomized clinical trial it is generally perceived that interpretation of a given estimate of the survival function…